Biotech

Irish co-founded Ochre Bio signs $1.3bn deal with German drugmaker

Jack O’Meara’s Oxford based life-sciences company uses machine learning to develop RNA therapies for a range of chronic conditions

Ochre Bio co-founder and chief executive Jack O’Meara